Longeveron Gains 10% Ahead Of Q4 Results

Shares of clinical stage biotechnology company Longeveron Inc. (LGVN) are climbing more than 10% Thursday morning ahead of fourth-quarter results, scheduled to be reported on Friday, March 11, before the market opens. The company’s lead investigational product LOMECEL-B is in Phase 1 and 2 studies in various indications, including aging […]

» Read more

Cara Therapeutics Adds 9% In Morning Trade

Shares of Cara Therapeutics, Inc. (CARA) are rising more than 9% Tuesday morning after analysts at JPMorgan upgraded the company to “Overweight”. The brokerage set a new price target of $20, up from the previous goal of $17, for the company on Tuesday. Cara stock, currently at $11.51, has traded […]

» Read more

SkyBridge Capital Founder: ‘Very Confident’ That Bitcoin Is Going to $100K by 2024

On Friday (March 4), former White House Director of Communications Anthony Scaramucci, who is the founder and managing partner of global alternative investment firm SkyBridge Capital (“SkyBridge”), shared his latest thoughts on Bitcoin. SkyBridge Capital is “an SEC-registered investment adviser and global alternative investment manager that invests in hedge funds, digital assets, private […]

» Read more

El Salvador President’s $1 Billion Bet on Bitcoin

On Thursday, American privately and publicly funded non-profit media organization National Public Radio (NPR) talked about the Bitcoin revolution that is taking place in El Salvador. As you may remember, the bill to make Bitcoin legal tender in El Salvador got passed by the Legislative Assembly on June 9 and the Bitcoin […]

» Read more
1 69 70 71 72 73 169